Literature DB >> 14966177

Spinocerebellar ataxia type 2 with glial cell cytoplasmic inclusions.

S Probst-Cousin1, T Acker, J T Epplen, M Bergmann, K H Plate, B Neundörfer, D Heuss.   

Abstract

Glial cell cytoplasmic inclusions were identified in a case of spinocerebellar ataxia type 2. These have not been reported before. The inclusions were found in low frequency in the dentate nucleus, cerebellar white matter, pontine transverse fibres, and the inferior olivary nucleus. They were of variable size and shape and expressed ubiquitin, thus resembling glial cytoplasmic inclusions in multiple system atrophy. However, their immunohistochemical profile was different as they did not show immunoreactivity for either tau protein or alpha-synuclein. There was no evidence of expanded polyglutamine tracts in these inclusions, which also failed to label with silver stains. As in many other neurodegenerative diseases, in spinocerebellar ataxia type 2 there may be pathogenic contributions of glial cells other than the common astrogliotic response to neuronal damage.

Entities:  

Mesh:

Year:  2004        PMID: 14966177      PMCID: PMC1738943          DOI: 10.1136/jnnp.2003.011825

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  3 in total

1.  Glial cell cytoplasmic inclusions in SCA2 do not express alpha-synuclein.

Authors:  José Berciano; Isidro Ferrer
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

2.  Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Authors:  Yang Yang; Su Yang; Jifeng Guo; Yiting Cui; Beisha Tang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-08-18       Impact factor: 6.167

Review 3.  Multiple system atrophy: genetic or epigenetic?

Authors:  Edith Sturm; Nadia Stefanova
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.